Search research articles
Contact Us
Filters
Showing results (1-10 of 140) with videos related to
Page
of 14
Sort By:
Postgraduate Medical Journal
|
July 1, 1990
Acquired von Willebrand disease associated with free lambda light chain monoclonal gammopathy, normal bleeding time and response to prednisone
A K Stewart, M F Glynn
Lancet (London, England)
|
May 3, 2000
White cells 2: impact of understanding the molecular basis of haematological malignant disorders on clinical practice
A K Stewart, A C Schuh
Blood
|
April 1, 1994
Immunoglobulin V regions and the B cell
A K Stewart, R S Schwartz
Critical Reviews in Oncology/Hematology
|
August 10, 1999
Recent progress in gene transfer into hematopoietic stem cells
C Lutzko, I D Dubé, A K Stewart
Stem Cells (Dayton, Ohio)
|
October 1, 1993
CD34 antigen: molecular features and potential clinical applications
D R Sutherland, A K Stewart, A Keating
Leukemia
|
April 9, 2005
t(11;14) does not predict long-term survival in myeloma
H Chang, X Y Qi, A K Stewart
Human Gene Therapy
|
March 10, 2001
Adenovirus-mediated human endostatin gene delivery demonstrates strain-specific antitumor activity and acute dose-dependent toxicity in mice
X Y Wen, Y Bai, A K Stewart
American Journal of Hematology
|
July 1, 1990
Acute leukemia evolving from multiple myeloma and co-expressing myeloid and plasma cell antigens
A K Stewart, J Freedman, M B Garvey
Cancer
|
December 5, 1998
The National Cancer Data Base report on patterns of care for adenocarcinoma of the rectum, 1985-95
J M Jessup, A K Stewart, H R Menck
Cancer
|
February 19, 2000
The National Cancer Data Base Report on treatment patterns for hepatocellular carcinomas: improved survival of surgically resected patients, 1985-1996
W G Cance, A K Stewart, H R Menck
Page
of 14
Search research articles
Search
Showing results (1-10 of 140) with videos related to
Sort By:
Page
of 14
Postgraduate Medical Journal
|
July 1, 1990
Acquired von Willebrand disease associated with free lambda light chain monoclonal gammopathy, normal bleeding time and response to prednisone
A K Stewart, M F Glynn
Lancet (London, England)
|
May 3, 2000
White cells 2: impact of understanding the molecular basis of haematological malignant disorders on clinical practice
A K Stewart, A C Schuh
Blood
|
April 1, 1994
Immunoglobulin V regions and the B cell
A K Stewart, R S Schwartz
Critical Reviews in Oncology/Hematology
|
August 10, 1999
Recent progress in gene transfer into hematopoietic stem cells
C Lutzko, I D Dubé, A K Stewart
Stem Cells (Dayton, Ohio)
|
October 1, 1993
CD34 antigen: molecular features and potential clinical applications
D R Sutherland, A K Stewart, A Keating
Leukemia
|
April 9, 2005
t(11;14) does not predict long-term survival in myeloma
H Chang, X Y Qi, A K Stewart
Human Gene Therapy
|
March 10, 2001
Adenovirus-mediated human endostatin gene delivery demonstrates strain-specific antitumor activity and acute dose-dependent toxicity in mice
X Y Wen, Y Bai, A K Stewart
American Journal of Hematology
|
July 1, 1990
Acute leukemia evolving from multiple myeloma and co-expressing myeloid and plasma cell antigens
A K Stewart, J Freedman, M B Garvey
Cancer
|
December 5, 1998
The National Cancer Data Base report on patterns of care for adenocarcinoma of the rectum, 1985-95
J M Jessup, A K Stewart, H R Menck
Cancer
|
February 19, 2000
The National Cancer Data Base Report on treatment patterns for hepatocellular carcinomas: improved survival of surgically resected patients, 1985-1996
W G Cance, A K Stewart, H R Menck
Page
of 14